Risk of serious infection is lower with certain psoriasis drugs

Large US study compares risks and benefits of common approaches

Patients with psoriasis who start treatment with apremilast, etanercept or ustekinumab have a lower risk of developing a serious infection than those prescribed methotrexate, a study shows.